caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1912022310

William Hurtado-SantiagoMD

NephrologyMayaguez, PRI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
52
Unique beneficiaries
—
Total services
116
Distinct HCPCS
3
Medicare payment
$8K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 104 Nephrology providers in PR — above median (cohort median 141).
REFERRAL NETWORK

Where William Hurtado-Santiago's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 10 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
ATLANTIS HEALTH CARE GROUP PUERTO RICO INC66293
Spectra East, Inc.
Clinical Laboratory · Rockleigh, NJ
4698
HOSPITAL DE LA CONCEPCION INC37167
Pedro Pagan Torres
Nephrology · San German, PR
3473
MAYAGUEZ MEDICAL CENTER DR RAMON EMETERIO BETANCES INC2571
Sibel Pabon Reyes
General Practice · Sabana Grande, PR
1874
BELLA VISTA HOSPITAL INC1537
Xiomara Quinones Vargas
General Practice · Winter Haven, FL
1448
BIO-MEDICAL APPLICATIONS OF AGUADILLA, INC.1324
Gabriel Monagas
Interventional Radiology · Mayaguez, PR
1142
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
4,642
Beneficiaries
—
Total drug cost
$1.5M
Distinct drugs
54
Brand share
43.8%
Top prescribed drugs
Dapagliflozin Propanediol880 claims
Atorvastatin Calcium475 claims
Empagliflozin445 claims
Losartan Potassium357 claims
Amlodipine Besylate244 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$60K
Payment records
100
By payment type
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$33K
Honoraria$17K
Travel and Lodging$7K
Food and Beverage$3K